Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study

BACKGROUND: Hyper progressive disease (HPD) describes the phenomenon that patients can’t benefit from immunotherapy but cause rapid tumor progression. HPD is a particular phenomenon in immunotherapy but lacks prediction methods. Our study aims to screen the factors that may forecast HPD and provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Yaping, Yang, Wenyu, Bai, Yibing, Tao, Haitao, Zhang, Fan, Wang, Lijie, Yang, Bo, Huang, Di, Han, Xiao, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543870/
https://www.ncbi.nlm.nih.gov/pubmed/37777758
http://dx.doi.org/10.1186/s12935-023-03070-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543870/
https://www.ncbi.nlm.nih.gov/pubmed/37777758
http://dx.doi.org/10.1186/s12935-023-03070-x

Ejemplares similares